BI-2865 |
| Catalog No.GC68760 |
BI-2865는 비공유성의 넓은 KRAS 억제제입니다. BI-2865는 KRAS WT, G12C, G12D, G12V 및 G13D 돌연변이와 결합하며 각각 KD 값은 6.9, 4.5, 32, 26 및 4.3 nM입니다. BI-2865는 KRAS G12C, G12D 또는 G12V 돌연변이를 발현하는 BaF3 세포의 증식을 억제합니다 (평균 IC50: 약 140 nM).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2937327-93-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for BI-2865
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for BI-2865
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *